AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

AUSTRALASIAN BIOTECHNOLOGY: Australian Cancer Technology to test p53 cancer vaccine.

Chemical Business Newsbase

| September 25, 2001 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Australian Cancer Technology Ltd, Australia, will be conducting the human trial of its p53 cancer vaccine in Aug 2001.

The vaccine is based on synthetic human antibodies from lymph nodes of colon cancer patients with mutated or …

Related articles from newspapers, magazines, journals, and more
Australian Cancer Technology Ltd to acquire US vaccine developer.
News wire article from: Asia Africa Intelligence Wire May 20, 2004 700+ words
AUSTRALIAN CANCER TECHNOLOGY REJECTS POLARTECHNICS MERGER TALK.
News wire article from: Asia Africa Intelligence Wire March 18, 2005 700+ words
Australian Cancer Technology reports doubling of mean survival time in...
News wire article from: Asia Africa Intelligence Wire February 8, 2005 700+ words
Australian Cancer Technology Ltd licenses Phase I/II pancreatic cancer drug.
News wire article from: Asia Africa Intelligence Wire September 10, 2004 700+ words
Australian Cancer Technology Ltd release: Galenica Pharmaceuticals...
News wire article from: Asia Africa Intelligence Wire June 23, 2004 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily